Specialty Chemicals company Anupam Rasayan India announced Q1FY26 results Total revenue for Q1FY26 was at Rs 4,907 million as compared to Rs 2,603 million in Q1FY25; up 89% YoY. EBITDA (incl. other income) was at Rs 1,292 million in Q1FY26 as compared to Rs 592 million in Q1FY25, up 118% and this would translate into 26% EBITDA margin in this quarter. Profit After Tax was at Rs 485 million in Q1FY26 as compared to Rs 122 million in Q1FY25; up 297% YoY. Anand Desai, Managing Director, Anupam Rasayan, said: “During Q1FY26, consolidated revenue stood at Rs 491 crore, registering a robust growth of 89% year-on-year. We strongly believe that the sectoral trends are in our favour, and we are witnessing a clear resurgence in growth. Our pharma and polymer businesses are performing well, coupled with a recovery in the Agrochemical segment. The USA and Japan markets have shown encouraging trends for Anupam Rasayan. During Q1FY26, total exports accounted for 58% of the total revenue from operations. With the two new agreements signed with Japanese and US-based multinational companies, our order book now stands at Rs 14,646 crore, reflecting the strong growth momentum in our business.” Result PDF